CryoPort Receives Coverage in Independent Report

According to the September 2009 report titled "Case Study: CryoPort
Turns to Cloud Computing to Develop Tomorrow's New Vaccines," the
software developed by KLATU Networks and deployed on a public
infrastructure-as-a-service (IaaS) leverages Amazon's EC2 cloud
platform and delivers cost efficiency and on-demand scalability when
it is needed. The solution integrates shipping logistics and
temperature monitoring into a single application. It orchestrates
data entry of multi-legs shipments, prepares FDA/Customs forms and
shipping labels, and electronically transmits all the shipping data
to the overnight courier for processing. During shipment, the system
captures detailed temperature logs and monitors each leg of the
shipment, stitching together multiple tracking numbers so that it
looks to the end customer like one transaction.

Larry Stambaugh, CEO of CryoPort, stated, "Having such an esteemed
group acknowledge the technological advancement we have made in the
shipping and tracking of temperature sensitive materials becomes a
major selling tool for the company. Third party recognition of our
technology will only enhance our ability to promote this service."

Rick Kriss, CEO of KLATU Networks, said, "Working with CryoPort, we
saw a perfect partnership opportunity to leverage our experience in
wireless cryogenic freezer monitoring and Web 2.0 technologies. We
spent a lot of time researching available solutions and looking at
what it would take to change the game from the end-customers
perspective."

About CryoPort, Inc.

CryoPort (www.cryoport.com) is commercializing proprietary,
technology-driven shipping products for use in the rapidly growing
global biotechnology and biopharmaceutical cold chain. The products
developed by CryoPort are essential components of the infrastructure
required for the clinical testing, research and end user deliver of
temperature-sensitive medicines and biomaterials in an increasingly
complex logistical environment.

SAFE HARBOR

This press release contains forward-looking statements. The words
"estimate," "possible" and "seeking" and similar expressions identify
forward-looking statements, which speak only as to the date the
statement was made. The company undertakes no obligation to publicly
update or revise any forward-looking statements, whether because of
new information, future events, or otherwise. Forward-looking
statements are inherently subject to risks and uncertainties, some of
which cannot be predicted, or quantified. Future events and actual
results could differ materially from those set forth in, contemplated
by, or underlying the forward-looking statements. The risks and
uncertainties to which forward-looking statements are subject
include, but are not limited to, the effect of government regulation,
competition and other material risks.

Contact:
Stuart Fine
Carpe DM, Inc.
908-469-1788

SOURCE: CryoPort Systems, Inc.

For full details on (CYRX) CYRX. (CYRX) has Short Term PowerRatings at TradingMarkets. Details on (CYRX) Short Term PowerRatings is available at This Link.